Protein compound macrophage migration inhibitory factor for diagnosing postmenopausal osteoporosis. [PDF]
Wang C +7 more
europepmc +1 more source
Romosozumab Versus Teriparatide for the Treatment of Postmenopausal Osteoporosis: An Overview of Systematic Reviews With Direct and Indirect Meta-Analyses. [PDF]
Bandeira TFGS +4 more
europepmc +1 more source
Curcumin-preconditioned bone marrow mesenchymal stem cell exosomes ameliorate postmenopausal osteoporosis by activating mitophagy in osteoblast-lineage cells. [PDF]
Li C, Jiang X, Zhou K, Sun Q, Shen H.
europepmc +1 more source
Synergistic Efficacy of Calcitriol Combined with Denosumab versus Calcitriol Alone in Postmenopausal Osteoporosis: A Retrospective Cohort Study. [PDF]
Li X, Hu M, Shen Y.
europepmc +1 more source
5-methoxyresorcinol mitigates postmenopausal osteoporosis through regulation of the PI3K-AKT-GSK3β signaling pathway and ROS homeostasis. [PDF]
Yang M +6 more
europepmc +1 more source
Estradiol regulates osteoclast sialylation via ST3Gal1 in postmenopausal osteoporosis. [PDF]
Dou C +9 more
europepmc +1 more source
Identification and verification of ferroptosis-related core gene in postmenopausal osteoporosis based on bioinformatics analysis. [PDF]
Ran D +6 more
europepmc +1 more source
Randomized controlled trial of an oral gastrin receptor antagonist for the treatment of postmenopausal osteoporosis. [PDF]
Schini M +7 more
europepmc +1 more source
Increase in serum DKK1 levels attenuates the anabolic response to romosozumab in postmenopausal osteoporosis. [PDF]
Adami G +10 more
europepmc +1 more source

